Apotex Health Corp.APTX.TO

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · apotex.com

Apotex Health is the largest Canadian-based pharmaceutical company, developing, manufacturing, and distributing generic pharmaceuticals, oncology biosimilars, branded specialty pharmaceuticals, and consumer health and wellness products across Canada, the United States, Mexico, and India. Founded in 1974 and headquartered in Toronto, it began trading on the TSX in June 2026 in the largest life-sciences IPO in TSX history, raising about $1.5 billion.

Key ratios

Operating cash flow growth

15.6%TTM

2026 15.6%2025 -2.9%

EPS growth

139.1%TTM

2026 139.1%

FCF / Sales

14.9%TTM

2026 14.9%2025 13.8%2024 16.6%

Net margin

10.7%TTM

2026 10.7%2025 4.5%2024 -5.0%

ROA

14.2%2026

2025 14.0%

ROE

29.7%TTM

2025 29.7%

Revenue growth

4.2%TTM

2026 4.2%2025 13.9%

Recent news

Apotex Announces First Quarter 2027 Results 2026-08-12 · CNW Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement 2026-07-16 · CNW Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026 2026-07-09 · CNW Apotex Expands U.S. Hospital Portfolio with Launch of Generic Infuvite Adult and Pediatric Injection 2026-07-08 · Newswire (CNW)Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals 2026-07-01 · Newswire (CNW)

Track APTX.TO in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer